Brooke-Spiegler syndrome tumor spectrum beyond the skin: A patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor

Future Oncology

Volumn 10, Issue 3, 2014, Pages 345-350

  Ponti, Giovanni ^a   Ruini, Cristel ^a   Girolomoni, Giampiero ^b   Pellacani, Giovanni ^a   Farnetani, Francesca ^a   Pastorino, Lorenza ^c   Ghiorzo, Paola ^c   Witkowski, Alexander Michal ^a   Bianchi Scarrà, Giovanna ^c   Tomasi, Aldo ^a   Loschi, Pietro ^a   Nasti, Sabina ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Brenner tumor; Brooke Spiegler syndrome; CYLD gene; Somatic CYLD mutations

Indexed keywords

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRENNER TUMOR; BROOKE SPIEGLER SYNDROME; CANCER PATIENT; CASE REPORT; CYLD GENE; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; FOUNDER EFFECT; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; GERM LINE; HUMAN; MIDDLE AGED; MISSENSE MUTATION; ONCOGENE; PREVALENCE; PRIORITY JOURNAL; RELATIVE; SKIN APPENDAGE DISEASE; SOMATIC MUTATION; TRICHOEPITHELIOMA;

BASE SEQUENCE; BRENNER TUMOR; CODON, NONSENSE; DNA MUTATIONAL ANALYSIS; FEMALE; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASTIC SYNDROMES, HEREDITARY; OVARIAN NEOPLASMS; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84896825529     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.13.198     Document Type: Article

References (24)

1. Brooke H. Epithelioma adenoides cysticum. Br. J. Dermatol. 4, 269 (1892). • First description of the phenotypic spectrum of the syndrome.
2. Spiegler H. [About endotheliomas of the skin]. Arch. Derm. Syph. 50, 163-176 (1899). • First description of the phenotypic spectrum of the syndrome.
3. Lian F, Cockerell CJ. Cutaneous appendage tumors: familial cylindromatosis and associated tumors update. Adv. Dermatol. 21, 217-234 (2005). (Pubitemid 41826752)
4. Ponti G, Nasti S, Losi L et al. Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes. J. Cutan. Pathol. 39, 366-371 (2012). • Highlights the existence of patients with a clinical phenotype that is not associated to mutations in CYLD or PTHC1 genes.
5. Ponti G, Pellacani G, Seidenari S et al. Cancer-associated genodermatoses: skin neoplasms as clues to hereditary tumor syndromes. Crit. Rev. Oncol. Hematol. 85, 239-256 (2013). • Provides a recent update and an interesting point of view on the rare cancer-associated genodermatoses, which have to be considered in the differential diagnosis of Brooke-Spiegler syndrome and in the clinical assessment of patients with cutaneous and visceral tumors.
6. Biggs PJ, Wooster R, Ford D et al. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene. Nat. Genet. 11, 441-443 (1995). • Provides strong evidence for linkage of cylindromatosis to loci on chromosome 16q12-q13.
7. Hellerbrand C, Bumes E, Bataille F et al. Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis 28, 21-27 (2007). (Pubitemid 44942623)
8. Strobel P, Zettl A, Ren Z et al. Spiradenocylindroma of the kidney: clinical and genetic findings suggesting a role of somatic mutation of the CYLD1 gene in the oncogenesis of an unusual renal neoplasm. Am. J. Surg. Pathol. 26, 119-124 (2002). (Pubitemid 34020000)
9. Hirai Y, Kawamata Y, Takeshima N et al. Conventional and array-based comparative genomic hybridization analyses of novel cell lines harboring HPV18 from glassy cell carcinoma of the uterine cervix. Int. J. Oncol. 24, 977-986 (2004).
10. Kikuno N, Shiina H, Urakami S et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int. J. Cancer 123, 552-560 (2008). (Pubitemid 351898412)
11. Zhong S, Fields CR, Su N, Pan YX, Robertson KD. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. Oncogene 26, 2621-2634 (2007). (Pubitemid 46632003)
12. Kazakov DV, Vanecek T, Nemcova J et al. Spectrum of tumors with follicular differentiation in a patient with the clinical phenotype of multiple familial trichoepitheliomas: a clinicopathological and molecular biological study, including analysis of the CYLD and PTCH genes. Am. J. Dermatopathol. 31, 819-827 (2009).
13. Kalina P, El-Azhary R. Brooke-Spiegler syndrome with multiple scalp cylindromas and bilateral parotid gland adenomas. Case Rep. Radiol. 2012, 249583 (2012).
14. Blake PW, Toro Jr. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling. Hum. Mut. 30, 1025-1036 (2009). • Provided a very interesting update on CYLD mutations and their biologic role.
15. Nasti S, Pastorino L, Bruno W et al. Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas. Clin. Genet. 76, 481-485 (2009). •• Discusses different Brooke-Spiegler syndrome case series with novel mutations, clearly enriching our knowledge on clinical and biomolecular features of the syndrome.
16. PolyPhen-2: prediction of functional effects of human nsSNPs. http://genetics.bwh.harvard.edu/pph2
17. SIFT algorithm. http://sift.jcvi.org/
18. Pmut software. http://mmb2.pcb.ub.es:8080/PMut
19. T-Coffee Multiple Sequence Alignment. www.ebi.ac.uk/Tools/msa/tcoffee
20. Sima R, Vanecek T, Kacerovska D et al. Brooke-Spiegler syndrome: report of 10 patients from 8 families with novel germline mutations: evidence of diverse somatic mutations in the same patient regardless of tumor type. Diagn. Mol. Pathol. 19, 83-91 (2010). • Discusses different Brooke-Spiegler syndrome case series with novel mutations, clearly enriching our knowledge on clinical and biomolecular features of the syndrome.
21. Grossmann P, Vanecek T, Steiner P et al. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens. Am. J. Dermatopathol. 35, 34-44 (2013). • Discusses different Brooke-Spiegler syndrome case series with novel mutations, clearly enriching our knowledge on clinical and biomolecular features of the syndrome.
22. Uede K, Yamamoto Y, Furukawa F. Brooke-Spiegler syndrome associated with cylindroma, trichoepithelioma, spiradenoma, and syringoma. J. Dermatol. 31, 32-38 (2004). (Pubitemid 38197214)
23. Bignell GR, Warren W, Seal S et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat. Genet. 25, 160-165 (2000). • Finally identified CYLD as the gene responsible for familial cylindromatosis. (Pubitemid 30394985)
24. Young AL, Kellermayer R, Szigeti R et al. CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes. Clin. Genet. 70, 246-249 (2006). • Suggested that familial cylindromatosis and multiple familial trichoepitheliomas represent phenotypic variation of a single genetic defect linked to CYLD mutations, better characterizing the syndrome. (Pubitemid 44219513)